Wall Street analyst estimates for Lifeward Ltd. (LFWD): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 4 |
| Hold | 0 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 5 |
| Avg rating (1-5) | 0.60 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.79 | ||
| 2026-08-14 | $-1.46 | $-1.39 | -5.0% |
| 2026-05-15 | $-6.70 | $-0.34 | -1870.6% |
| 2026-03-18 | $-3.60 | $-0.84 | -328.6% |
| 2025-11-14 | $-2.28 | $-0.14 | -1528.6% |
| 2025-08-14 | $-6.96 | $-3.00 | -132.0% |
| 2025-05-15 | $-5.52 | $-3.96 | -39.4% |
| 2025-03-07 | $-20.76 | $-2.40 | -765.0% |
Valuation Ratios
| Price / Book | 1.58 |
| EV / EBITDA | -4.27 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9M | $7.8M | $6.5M | $4.9M | $4.4M | $6.0M | $5.5M | $13.9M | $25.7M | $22.0M |
| Cost of Revenue | $5.1M | $4.7M | $3.7M | $2.1M | $2.2M | $3.1M | $3.6M | $9.4M | $17.4M | $13.6M |
| Gross Profit | $736000 | $3.1M | $2.8M | $2.7M | $2.2M | $2.9M | $1.9M | $4.5M | $8.2M | $8.4M |
| Research & Development | $9.0M | $6.0M | $7.3M | $5.3M | $3.5M | $2.9M | $4.0M | $4.1M | $4.6M | $3.2M |
| Selling, General & Admin | $22.1M | $19.1M | $14.7M | $11.4M | $10.7M | $12.6M | $17.0M | $23.9M | $23.1M | $22.1M |
| Operating Expenses | $31.2M | $25.1M | $22.0M | $16.8M | $14.2M | $15.6M | $21.0M | $28.1M | $27.8M | $25.3M |
| Operating Income | -$30.4M | -$22.0M | -$19.2M | -$14.0M | -$12.0M | -$12.7M | -$19.1M | -$23.6M | -$19.6M | -$16.9M |
| EBITDA | -$29.8M | -$21.5M | -$18.8M | -$13.7M | -$11.7M | -$12.4M | -$18.9M | -$20.3M | -$24.9M | -$19.3M |
| Interest Expense | $2.0M | $2.5M | $2.4M | $1.5M | $930000 | $25000 | $22000 | $20000 | $128000 | $295000 |
| Pre-tax Income | -$32.5M | -$24.6M | -$21.7M | -$15.5M | -$12.9M | -$12.6M | -$19.1M | -$22.1M | -$28.9M | -$20.0M |
| Income Tax | $3000 | $119000 | -$5000 | $7000 | $51000 | $94000 | $467000 | -$12000 | $43000 | -$55000 |
| Net Income | -$32.5M | -$24.7M | -$21.7M | -$15.6M | -$13.0M | -$12.7M | -$19.6M | -$22.1M | -$28.9M | -$19.9M |
| EPS | $-5179.56 | $-2567.76 | $-1236.48 | $-226.80 | $-68.88 | $-22.32 | $-26.40 | $-31.08 | $-39.96 | $-17.16 |
| EPS (Diluted) | $-5179.56 | $-2567.76 | $-1236.48 | $-226.80 | $-68.88 | $-22.32 | $-26.40 | $-31.08 | $-39.96 | $-17.16 |
| Shares Outstanding (Diluted) | $6273 | $9622 | $17523 | $68583 | $187603 | $570434 | $742308 | $710657 | $723983 | $11.6M |
Price
| Price | $6.91 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | IL |
Related companies: DHAI · IINN · INAB · LYRA · PTHL · RNAZ · SBFM
Explore sector: Healthcare · Medical - Devices
More sections of LFWD: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks